16-2597689-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_002613.5(PDPK1):c.1593C>T(p.Asn531=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000516 in 1,613,712 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00056 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00051 ( 1 hom. )
Consequence
PDPK1
NM_002613.5 synonymous
NM_002613.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.228
Genes affected
PDPK1 (HGNC:8816): (3-phosphoinositide dependent protein kinase 1) Enables 3-phosphoinositide-dependent protein kinase activity; phospholipase activator activity; and phospholipase binding activity. Involved in several processes, including cell surface receptor signaling pathway; regulation of protein kinase activity; and regulation of signal transduction. Acts upstream of or within intracellular signal transduction. Located in cell projection; cytosol; and plasma membrane. Implicated in prostate cancer. Biomarker of lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 16-2597689-C-T is Benign according to our data. Variant chr16-2597689-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3033227.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.228 with no splicing effect.
BS2
High AC in GnomAd4 at 86 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDPK1 | NM_002613.5 | c.1593C>T | p.Asn531= | synonymous_variant | 14/14 | ENST00000342085.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDPK1 | ENST00000342085.9 | c.1593C>T | p.Asn531= | synonymous_variant | 14/14 | 1 | NM_002613.5 | P1 | |
PDPK1 | ENST00000268673.11 | c.1212C>T | p.Asn404= | synonymous_variant | 11/11 | 1 | |||
PDPK1 | ENST00000441549.7 | c.*17C>T | 3_prime_UTR_variant | 12/12 | 1 | ||||
PDPK1 | ENST00000389224.7 | c.1512C>T | p.Asn504= | synonymous_variant | 14/14 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000565 AC: 86AN: 152216Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
86
AN:
152216
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000636 AC: 159AN: 250184Hom.: 1 AF XY: 0.000613 AC XY: 83AN XY: 135330
GnomAD3 exomes
AF:
AC:
159
AN:
250184
Hom.:
AF XY:
AC XY:
83
AN XY:
135330
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000510 AC: 746AN: 1461378Hom.: 1 Cov.: 31 AF XY: 0.000536 AC XY: 390AN XY: 726986
GnomAD4 exome
AF:
AC:
746
AN:
1461378
Hom.:
Cov.:
31
AF XY:
AC XY:
390
AN XY:
726986
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000565 AC: 86AN: 152334Hom.: 1 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74484
GnomAD4 genome
AF:
AC:
86
AN:
152334
Hom.:
Cov.:
32
AF XY:
AC XY:
45
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PDPK1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 18, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at